Tata Steel shares trim early gains; up nearly 1% at close.

 Trimming most of its early gains, shares of Tata Steel ended nearly one percent higher Wednesday on profit-taking in an overall weak broader market.

The stock ended the day with a gain of 0.89 percent at Rs 249.10 on the BSE. In intra-day, it surged 4.45 percent to Rs 257.90.

At the NSE, shares of the company settled at Rs 249.05 per scrip, up 0.91 percent.

In terms of volume, 29.26 lakh shares of the company changed hands at the BSE and over one crore shares were traded at NSE during the day.

The company's consolidated net profit jumped over two- fold for the reported quarter helped by strong sales from its Indian operation, cost optimisation and sale of non-core assets.

Its consolidated total income, however, fell 17 percent to Rs 30,300.33 crore during the April-June quarter this fiscal, from Rs 36,427.21 crore in the same period a year ago.

Total expenses fell 14 percent to Rs 28,872.59 crore from Rs 33,704.92 crore for the reported quarter.

In the broader market, the Sensex ended with a loss of 353.83 points at 27,512.26. 

Cadila Healthcare shares surge over 5% as Q1 net jumps.

 Shares of Cadila Healthcare Wednesday surged over 5 percent after the company reported a 47.11 percent rise in consolidated net profit for the first quarter ended June 30.

The drug firm's scrip climbed 5.16 percent to settle at Rs 2,017.30 on BSE. Intra-day session, it gained 6.34 percent to Rs 2,040.

At NSE, shares of the company ended at Rs 2,011.70, a gain of 5.12 percent.

The company's market capitalisation rose by Rs 2,028.92 crore to Rs 41,303.92 crore.

"For Q1FY16, Cadila Healthcare posted robust results," said Sarabjit Kour Nangra, VP Research - IT, Angel Broking.

Cadila Healthcare today reported a 47.11 percent rise in its consolidated net profit to Rs 353.39 crore for the first quarter ended June 30, mainly on account of robust sales.

The company had posted a net profit after taxes, minority interest and share of profit/(loss) of associates of Rs 240.21 crore for the corresponding period of the previous fiscal, Cadila Healthcare said.

Consolidated total income from operations of the company rose to Rs 2,500.65 crore during the quarter under consideration as against Rs 2,050.12 crore in the year ago period.

In a separate filing on BSE, Cadila Healthcare said its Board of Directors has considered and approved the sub-division (split) of one equity share of the company having a face value of Rs 5 into five equity shares of face value of Rs 1 each.